未登录 分享 收藏
分享 收藏
A predictive endocrine resistance index accurately stratifies luminal breast cancer treatment responders and nonresponders 一个预测性内分泌抵抗指数能够准确地对腔面型乳腺癌治疗反应者和非反应者进行分层。 Zhang, Guokun; Jurinovic, Vindi; Bartels, Stephan; Christgen, Matthias; Christgen, Henriette; Kandt, Leonie Donata; Mishieva, Lidiya; Ni, Hua; Raap, Mieke; Klein, Janin; Katzke, Anna-Lena; Hofmann, Winfried; Steinemann, Doris; Kates, Ronald E.; Gluz, Oleg; Graeser, Monika; Kummel, Sherko; Nitz, Ulrike; Plass, Christoph; Lehmann, Ulrich; Eulenburg, Christine zu; Mansmann, Ulrich; Gerhauser, Clarissa; Harbeck, Nadia; Kreipe, Hans H. 分享 收藏
Molecular determinants of response to neoadjuvant pembrolizumab plus chemotherapy in patients with high-risk, early-stage, triple-negative breast cancer: exploratory analysis of the open-label, multicohort phase 1b KEYNOTE-173 study 高风险、早期、三阴性乳腺癌患者对新辅助培美曲塞联合化疗反应的分子决定因素：开放标签、多队列1b期KEYNOTE-173研究的探索性分析 Dent, Rebecca; Cortes, Javier; Park, Yeon Hee; Munoz-Couselo, Eva; Kim, Sung-Bae; Sohn, Joohyuk; Im, Seock-Ah; Holgado, Esther; Foukakis, Theodoros; Kuemmel, Sherko; Yearley, Jennifer; Wang, Anran; Nebozhyn, Michael; Huang, Lingkang; Cristescu, Razvan; Jelinic, Petar; Karantza, Vassiliki; Schmid, Peter 分享 收藏
Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/ HER2neg breast cancer patients treated with upfront letrozole Fasching, Peter A.; Hack, Carolin C.; Nabieva, Naiba; Maass, Nicolai; Aktas, Bahriye; Kuemmel, Sherko; Thomssen, Christoph; Wolf, Christopher; Kolberg, Hans-Christian; Brucker, Cosima; Janni, Wolfgang; Dall, Peter; Schneeweiss, Andreas; Marme, Frederik; Suetterlin, Marc W.; Ruebner, Matthias; Theuser, Anna-Katharin; Kellner, Sara; Hofmann, Nadine M.; Bohm, Sybille; Almstedt, Katrin; Lueck, Hans-Joachim; Schmatloch, Sabine; Kalder, Matthias; Uleer, Christoph; Jurhasz-Boss, Ingolf; Hanf, Volker; Jackisch, Christian; Mueller, Volkmar; Rack, Brigitte; Belleville, Erik; Wallwiener, Diethelm; Rody, Achim; Rauh, Claudia; Bayer, Christian M.; Uhrig, Sabrina; Goossens, Chloe; Huebner, Hanna; Brucker, Sara Y.; Hein, Alexander; Fehm, Tanja N.; Haeberle, Lothar 分享 收藏
TNBC-DX genomic test in early-stage triple-negative breast cancer treated with neoadjuvant taxane-based therapy without immunotherapy TNBC-DX基因组检测在未接受免疫治疗的早期三阴性乳腺癌患者中的应用，该患者接受新辅助紫杉烷类药物治疗 Martin Jimenez, M.; Gluz, O.; Villacampa, G.; Lopez-Tarruella Cobo, S.; Nitz, U. A.; Cobo, S.; Braso-Maristany, F.; Christgen, M.; Jerez Gilarranz, Y.; Kummel, S.; Conte, B.; Diaz-Guardamino, I. Echavarria; Graeser-Mayer, M. K.; Kreipe, H.; Del Monte-Millan, M.; Herrero Lopez, B.; Perou, C. M.; Pare Brunet, L.; Prat, A.; Harbeck, N. 分享 收藏
Survival outcome of neoadjuvant endocrine therapy plus trastuzumab and pertuzumab (ET plus T plus P) vs. de-escalated chemotherapy (CT) plus T plus P in hormone receptor positive (HR+)/HER2+early breast cancer (EBC): WSG-TP-II trial 内分泌新辅助治疗联合曲妥珠单抗和帕妥珠单抗（ET plus T plus P）与降级化疗（CT）联合曲妥珠单抗和帕妥珠单抗（T plus P）在激素受体阳性（HR\(+\)/HER2\(+\)）早期乳腺癌（EBC）中的生存结局：WSG-TP-II试验 Gluz, O.; Nitz, U. A.; Christgen, M.; Kummel, S.; Holtschmidt, J.; Schumacher, J.; Hartkopf, A. D.; Luedtke-Heckenkamp, K.; Just, M.; von Schumann, R.; Polata, S.; Schinkoethe, T.; Graeser-Mayer, M. K.; Kates, R. E.; Wuerstlein, R.; Kreipe, H.; Harbeck, N. 分享 收藏
Integration of Pathological Criteria and Immunohistochemical Evaluation for Invasive Lobular Carcinoma Diagnosis: Recommendations From the European Lobular Breast Cancer Consortium De Schepper, Maxim; Koorman, Thijs; Richard, Francois; Christgen, Matthias; Vincent-Salomon, Anne; Schnitt, Stuart J.; van Diest, Paul J.; Zels, Gitte; Mertens, Freya; Maetens, Marion; Vanden Bempt, Isabelle; Harbeck, Nadia; Nitz, Ulrike; Graser, Monika; Kuemmel, Sherko; Gluz, Oleg; Weynand, Birgit; Floris, Giuseppe; Derksen, Patrick W. B.; Desmedt, Christine 分享 收藏
Neoadjuvant pembrolizumab plus chemotherapy/adjuvant pembrolizumab for early-stage triple-negative breast cancer: quality-of-life results from the randomized KEYNOTE-522 study Dent, Rebecca; Cortes, Javier; Pusztai, Lajos; McArthur, Heather; Kuemmel, Sherko; Bergh, Jonas; Denkert, Carsten; Park, Yeon Hee; Hui, Rina; Harbeck, Nadia; Takahashi, Masato; Untch, Michael; Fasching, Peter A.; Cardoso, Fatima; Haiderali, Amin; Jia, Liyi; Nguyen, Allison Martin; Pan, Wilbur; O'Shaughnessy, Joyce; Schmid, Peter 分享 收藏
Prognostic Implications of 68Ga-FAPI-46 PET/CT-Derived Parameters on Overall Survival in Various Types of Solid Tumors Watanabe, Masao; Fendler, Wolfgang P.; Grafe, Hong; Hirmas, Nader; Hamacher, Rainer; Lanzafame, Helena; Pabst, Kim M.; Hautzel, Hubertus; Aigner, Clemens; Kasper, Stefan; von Tresckow, Bastian; Stuschke, Martin; Kummel, Sherko; Lugnier, Celine; Hadaschik, Boris; Grunwald, Viktor; Zarrad, Fadi; Siveke, Jens T.; Herrmann, Ken; Weber, Manuel 分享 收藏
Diagnostic Accuracy of 68Ga-FAPI Versus 18F-FDG PET in Patients with Various Malignancies 68Ga-FAPI与18F-FDG PET在各种恶性肿瘤患者中的诊断准确性 Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lanzafame, Helena; Kasper, Stefan; Nader, Michael; Kesch, Claudia; von Tresckow, Bastian; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kuemmel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Hadaschik, Boris; Gruenwald, Viktor; Siveke, Jens T.; Herrmann, Ken; Fendler, Wolfgang P. 分享 收藏
Pembrolizumab Plus Chemotherapy Followed by Pembrolizumab in Patients With Early Triple-Negative Breast Cancer A Secondary Analysis of a Randomized Clinical Trial Takahashi, Masato; Cortes, Javier; Dent, Rebecca; Pusztai, Lajos; Mcarthur, Heather; Kuemmel, Sherko; Denkert, Carsten; Park, Yeon Hee; Im, Seock-Ah; Ahn, Jin-Hee; Mukai, Hirofumi; Huang, Chiun-Sheng; Chen, Shin-Cheh; Kim, Min Hwan; Jia, Liyi; Li, Xin Tong; Tryfonidis, Konstantinos; Karantza, Vassiliki; Iwata, Hiroji; Schmid, Peter 分享 收藏
Phase III study of neoadjuvant pembrolizumab or placebo plus chemotherapy followed by adjuvant pembrolizumab or placebo for early-stage triple-negative breast cancer (TNBC): KEYNOTE-522 Korean subgroup analysis Park, Y. H.; Im, S-A.; Ahn, J-H.; Kim, M. H.; Cortes, J.; Dent, R. A.; Pusztai, L.; McArthur, H. L.; Kummel, S.; Denkert, C.; O'Shaughnessy, J.; Mouret-Reynier, M-A.; Ferreira, M. I. R.; Cortes, M. Gion; Boileau, J-F.; Hui, R.; Zhu, Y.; Pan, W.; Karantza, V. V.; Schmid, P. 分享 收藏
Pembrolizumab or placebo plus chemotherapy followed by pembrolizumab or placebo for early-stage TNBC: Updated EFS results from the phase III KEYNOTE-522 study Schmid, P.; Cortes, J.; Dent, R. A.; Pusztai, L.; McArthur, H. L.; Kummel, S.; Denkert, C.; Park, Y. H.; Hui, R.; Harbeck, N.; Takahashi, M.; Foukakis, T.; Reynier, M. A. Mouret; Ferreira, M. I. R.; Im, S. A.; Cardoso, F.; Ding, Y.; Pan, W.; Tryfonidis, K. E.; O'Shaughnessy, J. 分享 收藏
Multiparametric prognostic score in early HR+/HER2-breast cancer: Impact of recurrence score, clinical-pathological factors, gene mutations and histology Gluz, O.; Christgen, M.; Eulenburg, C. Zu; Nitz, U. A.; Kummel, S.; Braun, M.; Aktas, B.; Luedtke-Heckenkamp, K.; Forstbauer, H.; Grischke, E. M.; Schumacher, C.; Baehner, R. F. L.; Kates, R. E.; Graeser, M.; Wurstlein, R.; Kreipe, H.; Harbeck, N. 分享 收藏
The effect of denosumab on disseminated tumor cells (DTCs) of breast cancer patients with neoadjuvant treatment: a GeparX translational substudy Wimberger, Pauline; Blohmer, Jens-Uwe; Krabisch, Petra; Link, Theresa; Just, Marianne; Sinn, Bruno Valentin; Simon, Eike; Solbach, Christine; Fehm, Tanja; Denkert, Carsten; Kuehn, Cristin; Rhiem, Kerstin; Tesch, Hans; Kuemmel, Sherko; Petzold, Andrea; Stoetzer, Oliver; Meisel, Cornelia; Kuhlmann, Jan Dominik; Nekljudova, Valentina; Loibl, Sibylle 分享 收藏
Fibroblast-Activation Protein PET and Histopathology in a Single-Center Database of 324 Patients and 21 Tumor Entities 在324例患者和21个肿瘤实体的单中心数据库中成纤维细胞活化蛋白PET和组织病理学 Hirmas, Nader; Hamacher, Rainer; Sraieb, Miriam; Ingenwerth, Marc; Kessler, Lukas; Pabst, Kim M.; Barbato, Francesco; Lueckerath, Katharina; Kasper, Stefan; Nader, Michael; Schildhaus, Hans-Ulrich; Kesch, Claudia; von Tresckow, Bastian; Hanoun, Christine; Hautzel, Hubertus; Aigner, Clemens; Glas, Martin; Stuschke, Martin; Kummel, Sherko; Harter, Philipp; Lugnier, Celine; Uhl, Waldemar; Niedergethmann, Marco; Hadaschik, Boris; Grunwald, Viktor; Siveke, Jens T.; Herrmann, Ken; Fendler, Wolfgang P. 分享 收藏
Neoadjuvant pembrolizumab/placebo plus chemo, followed by adjuvant pembrolizumab/placebo in early TNBC: Asian subgroup Takahashi, Masato; Cortes, Javier; Dent, Rebecca; Pusztai, Lajos; Mcarthur, Heather; Kuemmel, Sherko; Denkert, Carsten; Park, Yeon Hee; Im, Seock-Ah; Ahn, Jin-Hee; Mukai, Hirofumi; Huang, Chiun-Sheng; Chen, Shin-Cheh; Kim, Min Hwan; Jia, Liyi; Li, Xin Tong; Tryfonidis, Konstantinos; Karantza, Vassiliki; Iwata, Hiroji; Schmid, Peter 分享 收藏
The impact of anthracyclines in intermediate and high-risk HER2-negative early breast cancer-a pooled analysis of the randomised clinical trials PlanB and SUCCESS C de Gregorio, Amelie; Janni, Wolfgang; Friedl, Thomas W. P.; Nitz, Ulrike; Rack, Brigitte; Schneeweiss, Andreas; Kates, Ronald; Fehm, Tanja; Kreipe, Hans; Christgen, Matthias; Kuemmel, Sherko; Trapp, Elisabeth; Wuerstlein, Rachel; Haertkopf, Andreas; Clemens, Michael; Reimer, Toralf; Haeberle, Lothar; Fasching, Peter A.; Gluz, Oleg; Harbeck, Nadia 分享 收藏
KEYNOTE-522 study of neoadjuvant pembrolizumab plus chemotherapy vs placebo plus chemotherapy, followed by adjuvant pembrolizumab vs placebo for early-stage TNBC: Event-free survival sensitivity and subgroup analyses Schmid, Peter; Cortes, Javier; Dent, Rebecca; Pusztai, Lajos; McArthur, Heather; Kummel, Sherko; Bergh, Jonas; Denkert, Carsten; Park, Yeon Hee; Hui, Rina; Harbeck, Nadia; Takahashi, Masato; Untch, Michael; Fasching, Peter A.; Cardoso, Fatima; Andersen, Jay; Patt, Debra; Danso, Michael; Ferreira, Marta; Mouret-Reynier, Marie-Ange; Im, Seock-Ah; Ahn, Jin-Hee; Gion, Maria; Baron-Hay, Sally; Boileau, Jean-Francois; Zhu, Yalin; Pan, Wilbur; Tryfonidis, Konstantinos; Karantza, Vassiliki; O'Shaughnessy, Joyce 分享 收藏
.png){kind=icon}
.png){kind=icon}
.png)
OAAI
.png){kind=icon}
分享.png){kind=icon}
收藏
.png)
ANNALS OF ONCOLOGY